Timothy R. Rebbeck

Dr. Timothy R. Rebbeck is the Vincent L. Gregory, Jr. Professor of Cancer Prevention at the Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute. He directs the Zhu Family Center for Global Cancer Prevention and the Center for Global Health Equity, focusing on genetic, molecular, and epidemiological factors in cancer risk and disparities.

• Key Initiatives: MADCaP consortium; NCI-funded African Cancer STARS training program
• Funding: Continuous NIH support since 1994

His cancer genetics research spans prostate cancer disparities, BRCA1/2 mutation risk modeling, and global health equity, with recent work on precision interception approaches for aggressive prostate cancer in African American men and multi-ancestry polygenic risk scores. Over 65 trainees mentored, now in academic roles.

Scientific accolades include the Joseph F. Fraumeni, Jr. Award and ASCO-American Cancer Society Lecture. His 15 most recent articles (2022-2025) cover:

• Prostate cancer genomics in diverse populations
• Somatic tumor profiling in veterans
• Social/environmental determinants of telomere length
• Global cancer registries in low-resource settings
• Health disparities in screening/treatment access
• Evolutionary roots of cancer susceptibility

Dr. Rebbeck's work bridges genetic epidemiology, clinical translational research, and international capacity building, with significant contributions to understanding and addressing cancer burden disparities across ancestry groups.